First Time Loading...

Zhejiang Gongdong Medical Technology Co Ltd
SSE:605369

Watchlist Manager
Zhejiang Gongdong Medical Technology Co Ltd Logo
Zhejiang Gongdong Medical Technology Co Ltd
SSE:605369
Watchlist
Price: 52.2 CNY 10.01% Market Closed
Updated: Apr 29, 2024
Section:
 

Relative Value

The Relative Value of one Zhejiang Gongdong Medical Technology Co Ltd stock under the Base Case scenario is 73.27 CNY. Compared to the current market price of 52.2 CNY, Zhejiang Gongdong Medical Technology Co Ltd is Undervalued by 29%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
73.27 CNY
Undervaluation 29%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

5.8
P/S
P/S
Price to Sales
5.8
vs History
71
vs Industry
25
Median 3Y
8.1
Median 5Y
8.1
Industry
2.4
Forward
5.3
More Details
55.3
P/E
P/E
Price to Earnings
55.3
vs History
8
vs Industry
9
Median 3Y
37.1
Median 5Y
35.9
Industry
23.2
Forward
34.5
More Details
31
P/OCF
P/OCF
Price to OCF
31
vs History
53
vs Industry
14
Median 3Y
33.2
Median 5Y
32.8
Industry
15.5
More Details
52.4
P/FCFE
P/FCFE
Price to FCFE
52.4
vs History
57
vs Industry
13
Median 3Y
60.3
Median 5Y
56.1
Industry
23.5
More Details
3.6
P/B
P/B
Price to Book Value
3.6
vs History
86
vs Industry
27
Median 3Y
7.4
Median 5Y
7.1
Industry
2.2
More Details
5.4
EV/S
EV/S
Enterprise Value to Sales
5.4
vs History
75
vs Industry
25
Median 3Y
7.6
Median 5Y
7.3
Industry
2.5
Forward
4.8
More Details
17.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
17.1
vs History
62
vs Industry
13
Median 3Y
19.1
Median 5Y
18.9
Industry
5.2
More Details
54.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
54.3
vs History
8
vs Industry
4
Median 3Y
33.5
Median 5Y
31.9
Industry
12.5
Forward
24.8
More Details
54.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
54.3
vs History
8
vs Industry
7
Median 3Y
33.5
Median 5Y
31.9
Industry
17.2
More Details
28.3
EV/OCF
EV/OCF
Enterprise Value to OCF
28.3
vs History
62
vs Industry
17
Median 3Y
31.1
Median 5Y
30.4
Industry
15.1
More Details
48
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
48
vs History
64
vs Industry
12
Median 3Y
55.8
Median 5Y
52
Industry
19.7
More Details
4.1
EV/IC
EV/IC
Enterprise Value to IC
4.1
vs History
88
vs Industry
23
Median 3Y
11.9
Median 5Y
11.3
Industry
2
More Details

Multiples Across Competitors

Competitors Multiples
Zhejiang Gongdong Medical Technology Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Zhejiang Gongdong Medical Technology Co Ltd
SSE:605369
5.9B CNY 5.8 55.3 54.3 54.3
JP
Hoya Corp
TSE:7741
6.4T JPY 8.6 38.5 23.4 28.9
CH
Alcon AG
SIX:ALC
35.7B CHF 4.1 40 17.8 36.2
DK
Coloplast A/S
CSE:COLO B
193.6B DKK 7.7 39.8 26.2 30.4
US
Align Technology Inc
NASDAQ:ALGN
23.2B USD 6 52.1 27.8 33.8
US
Cooper Companies Inc
NYSE:COO
17.7B USD 4.8 60.7 22.3 37.8
KR
HLB Inc
KOSDAQ:028300
14.2T KRW 333.3 -75.6 -123.3 -113.7
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
56.8B CNY 14.5 34.3 29.9 29.9
UK
ConvaTec Group PLC
LSE:CTEC
5.3B GBP 3.1 50.7 46.8 50.9
US
DENTSPLY SIRONA Inc
NASDAQ:XRAY
6.3B USD 1.6 -48 12.2 26.3
CA
Bausch + Lomb Corp
NYSE:BLCO
5.2B USD 1.3 -20 15.8 44.1

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 132,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.